Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

August 16, 2022 08:46 ET | Source: OJO Labs

OJO Labs Named to Inc. Magazine’s List of Fastest-Growing Private Companies for Second Consecutive Year

AUSTIN, Texas, Aug. 16, 2022 (GLOBE NEWSWIRE) -- Today, Inc. revealed that OJO Labs, for the second year in a row, was named on its annual Inc. 5000 list at No. 355. The most prestigious ranking of...
August 16, 2022 08:00 ET | Source: Xevant, Inc.

Xevant Ranks No. 1 on the Inc. 5000 2022 List as the Fastest Growing Private Software Company in America

LEHI, Utah, Aug. 16, 2022 (GLOBE NEWSWIRE) -- Today, Inc. revealed that Xevant is No. 28 on its annual Inc. 5000 list, the most prestigious ranking of the fastest-growing private companies in...
July 22, 2022 16:02 ET | Source: Revolution Medicines, Inc.

Revolution Medicines Announces Closing of Upsized Public Offering of Common Stock and Full Exercise of Underwriters' Option to Purchase Additional Shares

REDWOOD CITY, Calif., July 22, 2022 (GLOBE NEWSWIRE) -- Revolution Medicines, Inc. (Nasdaq: RVMD), a clinical-stage oncology company developing targeted therapies for RAS-addicted cancers, today...
July 19, 2022 22:41 ET | Source: Revolution Medicines, Inc.

Revolution Medicines Announces Pricing of Upsized $230.0 Million Public Offering of Common Stock

REDWOOD CITY, Calif., July 19, 2022 (GLOBE NEWSWIRE) -- Revolution Medicines, Inc. (Nasdaq: RVMD), a clinical-stage oncology company developing targeted therapies for RAS-addicted cancers, today...
July 19, 2022 16:01 ET | Source: Revolution Medicines, Inc.

Revolution Medicines Announces Commencement of Public Offering of Common Stock

REDWOOD CITY, Calif., July 19, 2022 (GLOBE NEWSWIRE) -- Revolution Medicines, Inc. (Nasdaq: RVMD), a clinical-stage oncology company developing targeted therapies for RAS-addicted cancers, today...
June 28, 2022 07:00 ET | Source: Revolution Medicines, Inc.

Revolution Medicines Advances First RAS(ON) Inhibitor into Clinic, Dosing First Patient in Phase 1/1b Trial of RMC-6236

First-in-class, oral, RAS(ON) Inhibitor being evaluated initially in patients with cancers driven by KRASG12 mutations Sushil Patel, Ph.D., industry veteran with commercial oncology expertise,...
May 10, 2022 13:09 ET | Source: First Orion Corp.

First Orion Named as an Inc. Magazine’s Best Workplaces for 2022

NORTH LITTLE ROCK, Ark. , May 10, 2022 (GLOBE NEWSWIRE) -- First Orion has been named to Inc. magazine’s annual Best Workplaces list. Featured in the May/June 2022 issue, hitting newsstands on May...
April 12, 2022 08:30 ET | Source: EarthScout

EarthScout Launches New Mini Wireless Soil Cub Field Sensor

MINNEAPOLIS, April 12, 2022 (GLOBE NEWSWIRE) -- Agtech company EarthScout today announced a new addition to its scalable line of agriculture smart products that help farmers and food producers...
March 24, 2022 08:00 ET | Source: Brain Scientific Inc.

Piezo Motion’s Precise Motor Technology Is Now Available in Germany

LAKEWOOD RANCH, Fla., March 24, 2022 (GLOBE NEWSWIRE) -- via InvestorWire -- Piezo Motion, a Brain Scientific (OTCQB:BRSF) company, and MEV Elektronik Service GmbH, a manufacturing representative...
March 15, 2022 16:03 ET | Source: OJO Labs

With a Two-Year Revenue Growth of 803%, OJO Labs Ranks No. 16 on Inc. Magazine’s List of the Southwest Region’s Fastest-Growing Private Companies

AUSTIN, Texas, March 15, 2022 (GLOBE NEWSWIRE) -- Inc. magazine today revealed that OJO Labs is No. 16 on its third annual Inc. 5000 Regionals Southwest list, the most prestigious ranking of the...